Company Directory

Rani Therapeutics was developed at InCube Labs, a multi-disciplinary life sciences R&D lab focused on developing breakthrough medical innovations. Rani Therapeutics has developed a novel system, the "robotic pill", for oral delivery of large drug molecules including peptides, proteins and antibodies.

Raphas is a technology company focused on skin-based drug delivery techniques able to effectively permeate the skin barrier. The company is developing an innovative drug delivery system based on a microneedle patch that is effortless and painless to use for self-administration.

Raumedic is a polymer specialist that develops and produces customised components for the medical and pharmaceutical industries, including tubing, catheters and moulded parts as well as complex groups of components and systems for diagnostic and therapeutic uses.

Respiratory Drug Delivery, RDD^®, hosts conferences in the US, Europe and Asia provide a venue for expert speakers to cover topics including: new therapeutic opportunities and drug delivery technologies, regulatory science and novel in vitro, in vivo and clinical testing methods.

Recipe Design is a strategic design consultancy specialising in the healthcare and home sectors. The company uses Meaning Centred Design, a unique process that helps clients understand how their customers and end users perceive their brand and proposition.

Recipharm is a pharmaceutical contract development and manufacturing organisation. Recipharm offers manufacturing services for pharmaceuticals in various dosage forms, production of clinical trial material and APIs, and pharmaceutical product development.

Renaissance Lakewood is a global CDMO for pharmaceutical and biotech companies, with more than 20 years of experience in nasal sprays and sterile injectable dosage forms.

Research Center Pharmaceutical Engineering is an independent research centre. It develops physicochemical and predictive bases for addressing drug formulation and delivery challenges for oral, buccal, inhalation and implant products of small- and large-molecule therapeutics.

Resyca, a joint venture between Recipharm and Medspray, develops next-generation soft mist inhalers, including prefilled syringes inhalers, for the delivery of both small and large molecules, and designed to optimise lung deposition whilst minimising oropharyngeal deposition.